Ocuphire Pharma
is the first approved eyedrop for presbyopia | Ocuphire Pharma
Company
Deck Type
Deck date
January 2022
Slide
104 of 114
Related slides by other companies
Pershing Square
Activist
July 2014
a large at the currently elevated share price would be value destructive leveraged of up to billion compared to a total share for its peers | Pershing Square
Carlyle
Investor Day
February 2021
we invest significant amounts of capital for many of the world investors | Carlyle
Advent
Investor Day
July 2022
hydrogen fuel cell markets booming | Advent
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights